The c-Myc/pT3 HCC lesions demonstrated significant higher proliferation rate than c-Myc/TGFβ1 livers, as determined by anti-Ki67 immunohistochemistry (Fig. 2c, d). This evidence concerns the gene MYC and hepatocellular carcinoma.